Circulating autoantibodies in multiple sclerosis. 1990

L Tomasević, and J Nikolić, and M Lukić, and Z Lević
Department of Allergollogy and Clinical Immunology, University Clinical Centre, Belgrade.

By using indirect immunofluorescence method, we analyzed the presence of antinuclear, anticardiac, microsomal, parietal-cell, smooth-muscle and mitochondrial antibodies in sera of 33 patients with definite multiple sclerosis (MS), without clinical evidence of associated autoimmune disorder, and 14 patients with other neurological disorders (OND). In MS patients, the prevalence of both organ-specific and non-organ-specific antibodies was significantly higher (p less than 0.05) than in OND patients. In both groups, the titers of circulating antibodies were low. The presence of low levels of autoantibodies in sera of MS patients might be the result of immunodysregulation in MS.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody

Related Publications

L Tomasević, and J Nikolić, and M Lukić, and Z Lević
February 1990, Italian journal of neurological sciences,
L Tomasević, and J Nikolić, and M Lukić, and Z Lević
August 2013, Iranian journal of allergy, asthma, and immunology,
L Tomasević, and J Nikolić, and M Lukić, and Z Lević
August 2008, Laboratory investigation; a journal of technical methods and pathology,
L Tomasević, and J Nikolić, and M Lukić, and Z Lević
January 1968, Studii si cercetari de neurologie,
L Tomasević, and J Nikolić, and M Lukić, and Z Lević
September 2013, Neurology,
L Tomasević, and J Nikolić, and M Lukić, and Z Lević
July 2015, International journal of molecular sciences,
L Tomasević, and J Nikolić, and M Lukić, and Z Lević
April 2018, Multiple sclerosis (Houndmills, Basingstoke, England),
L Tomasević, and J Nikolić, and M Lukić, and Z Lević
January 1991, Neurologia i neurochirurgia polska,
L Tomasević, and J Nikolić, and M Lukić, and Z Lević
February 2017, Clinical and experimental immunology,
L Tomasević, and J Nikolić, and M Lukić, and Z Lević
May 1984, Ceskoslovenska neurologie a neurochirurgie,
Copied contents to your clipboard!